SK287198B6 - Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie - Google Patents

Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie Download PDF

Info

Publication number
SK287198B6
SK287198B6 SK91-2000A SK912000A SK287198B6 SK 287198 B6 SK287198 B6 SK 287198B6 SK 912000 A SK912000 A SK 912000A SK 287198 B6 SK287198 B6 SK 287198B6
Authority
SK
Slovakia
Prior art keywords
cells
antigen
antibody
sequence
binding
Prior art date
Application number
SK91-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK912000A3 (en
Inventor
Fernando J. Bazan
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287198(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK912000A3 publication Critical patent/SK912000A3/sk
Publication of SK287198B6 publication Critical patent/SK287198B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SK91-2000A 1997-07-25 1998-07-24 Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie SK287198B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (fr) 1997-07-25 1998-07-24 Cytokine mammalienne: interleukine-b30 et reactifs correspondants

Publications (2)

Publication Number Publication Date
SK912000A3 SK912000A3 (en) 2000-09-12
SK287198B6 true SK287198B6 (sk) 2010-03-08

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
SK91-2000A SK287198B6 (sk) 1997-07-25 1998-07-24 Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie

Country Status (29)

Country Link
EP (3) EP2233574A1 (fr)
JP (5) JP4316133B2 (fr)
KR (1) KR100666835B1 (fr)
CN (2) CN1271387A (fr)
AR (2) AR017510A1 (fr)
AT (1) ATE443142T1 (fr)
AU (1) AU741046B2 (fr)
BR (1) BR9811039A (fr)
CA (1) CA2296272C (fr)
CO (1) CO4810232A1 (fr)
CZ (1) CZ300958B6 (fr)
DE (1) DE69841161D1 (fr)
DK (2) DK2100959T3 (fr)
ES (2) ES2610483T3 (fr)
HK (1) HK1024932A1 (fr)
HU (1) HU230629B1 (fr)
ID (1) ID28114A (fr)
IL (3) IL134068A0 (fr)
LT (1) LT2100959T (fr)
MY (1) MY157028A (fr)
NO (1) NO329329B1 (fr)
NZ (1) NZ502391A (fr)
PE (1) PE20000183A1 (fr)
PL (1) PL197150B1 (fr)
PT (2) PT2100959T (fr)
SK (1) SK287198B6 (fr)
TW (1) TWI237057B (fr)
WO (1) WO1999005280A1 (fr)
ZA (1) ZA986596B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
DE69834938T2 (de) * 1997-10-23 2007-02-01 Nippon Institute For Biological Science, Oume Granulozyten-kolonie-stimulierender faktor aus der katze
WO1999040195A1 (fr) * 1998-02-06 1999-08-12 Schering Corporation Proteines de recepteurs de mammiferes; reactifs et procedes apparentes
ATE474849T1 (de) 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
DE60038304T3 (de) * 1999-09-09 2017-04-06 Merck Sharp & Dohme Corp. Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
EP1905832A3 (fr) 1999-09-09 2009-09-09 Schering Corporation Interleukin-12 P40 et interleukin B30 de mammifères, anticorps, utilisation dans des compositions pharmaceutiques
DE60328823D1 (de) 2002-10-30 2009-09-24 Genentech Inc Hemmung von il-17 produktion
JP2007515939A (ja) 2003-05-09 2007-06-21 セントカー・インコーポレーテツド IL−23p40特異的免疫グロブリン由来タンパク質、組成物、方法および用途
WO2005108425A1 (fr) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Reseau antigene il-23 p19 et utilisations
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
JP2009501006A (ja) 2005-06-30 2009-01-15 セントカー・インコーポレーテツド 抗il−23抗体、組成物、方法および用途
PL1971366T3 (pl) 2005-12-29 2015-01-30 Janssen Biotech Inc Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
WO2007147019A2 (fr) 2006-06-13 2007-12-21 Zymogenetics, Inc. Antagonistes d'il-17 et d'il-23 et leurs procédés d'utilisation
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Il-23拮抗劑於治療感染之用途
US8975382B2 (en) 2007-11-27 2015-03-10 Ablynx N.V. Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
KR101508086B1 (ko) 2008-05-05 2015-04-07 노비뮨 에스 에이 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법
RU2605318C2 (ru) 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
PT2635601T (pt) 2010-11-04 2016-09-27 Boehringer Ingelheim Int Anticorpos anti-il-23
EP4039275A1 (fr) 2012-05-03 2022-08-10 Boehringer Ingelheim International GmbH Anticorps anti-il-23p19
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
WO2014149425A1 (fr) 2013-03-15 2014-09-25 Amgen Inc. Méthodes de traitement du psoriasis à l'aide d'un anticorps anti-il-23
EP3172339A1 (fr) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarqueurs utiles dans le traitement de maladies associées à l'il-23a
BR112017004169A2 (pt) 2014-09-03 2017-12-05 Boehringer Ingelheim Int composto direcionado à il-23a e ao tnf-alfa e usos do mesmo
KR20180063127A (ko) 2015-09-17 2018-06-11 암젠 인크 Il23 경로 바이오마커를 사용한, il23-길항제에 대한 임상 반응의 예측
KR20180096633A (ko) 2015-12-22 2018-08-29 암젠 인크 Il23-길항제에 대한 임상적 반응의 예측인자로서의 ccl20
SG11202100185VA (en) 2018-07-13 2021-02-25 Astrazeneca Collaboration Ventures Llc Treating ulcerative colitis with brazikumab
CN113395979A (zh) 2018-11-20 2021-09-14 詹森生物科技公司 用抗il-23特异性抗体治疗银屑病的安全且有效的方法
AU2020279987A1 (en) 2019-05-23 2021-11-18 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
US11396541B2 (en) 2019-12-20 2022-07-26 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 P19 antibodies and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
ATE474849T1 (de) * 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
HK1024932A1 (en) 2000-10-27
AR017510A1 (es) 2001-09-12
KR100666835B1 (ko) 2007-01-11
PL338262A1 (en) 2000-10-09
DE69841161D1 (de) 2009-10-29
JP2001511347A (ja) 2001-08-14
NO20000343L (no) 2000-03-24
CA2296272A1 (fr) 1999-02-04
PT2100959T (pt) 2017-01-09
HU230629B1 (hu) 2017-04-28
MY157028A (en) 2016-04-15
JP2005323610A (ja) 2005-11-24
LT2100959T (lt) 2017-01-10
AR086483A2 (es) 2013-12-18
CA2296272C (fr) 2012-03-13
IL134068A (en) 2010-11-30
ATE443142T1 (de) 2009-10-15
ES2331762T3 (es) 2010-01-14
TWI237057B (en) 2005-08-01
NO20000343D0 (no) 2000-01-24
CN1271387A (zh) 2000-10-25
JP2010011863A (ja) 2010-01-21
KR20010022214A (ko) 2001-03-15
AU741046B2 (en) 2001-11-22
BR9811039A (pt) 2000-08-08
CZ2000263A3 (cs) 2000-06-14
NZ502391A (en) 2002-12-20
DK1002084T3 (da) 2010-01-04
JP2013034480A (ja) 2013-02-21
HUP0004019A2 (en) 2001-03-28
ES2610483T3 (es) 2017-04-27
CZ300958B6 (cs) 2009-09-23
EP2100959A3 (fr) 2009-10-14
CN101851286A (zh) 2010-10-06
EP1002084B1 (fr) 2009-09-16
EP2233574A1 (fr) 2010-09-29
HUP0004019A3 (en) 2003-08-28
JP2015037405A (ja) 2015-02-26
EP1002084A1 (fr) 2000-05-24
IL134068A0 (en) 2001-04-30
NO329329B1 (no) 2010-09-27
WO1999005280A1 (fr) 1999-02-04
PE20000183A1 (es) 2000-03-11
EP2100959B1 (fr) 2016-12-07
JP4316133B2 (ja) 2009-08-19
SK912000A3 (en) 2000-09-12
ID28114A (id) 2001-05-03
CO4810232A1 (es) 1999-06-30
IL205765A0 (en) 2011-07-31
PT1002084E (pt) 2009-12-16
EP2100959A2 (fr) 2009-09-16
PL197150B1 (pl) 2008-03-31
DK2100959T3 (en) 2017-01-30
IL205765A (en) 2015-07-30
ZA986596B (en) 1999-02-08
AU8589498A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
US8765914B2 (en) Interleukin-B30 proteins
KR100666835B1 (ko) 인터루킨-b30의 폴리펩타이드, 이를 암호화하는 뉴클레오타이드 및 이에 대한 항체를 포함하는 약제학적 조성물
CA2343979C (fr) Interleukine humaine b50, ses utilisations therapeutiques
JP2003500010A (ja) 哺乳動物サイトカイン;関連試薬および方法
JP2015180228A (ja) 哺乳動物サイトカイン;関連試薬
US20040192891A1 (en) Mammalian cytokines; related reagents and methods
AU773669B2 (en) Mammalian cytokine: interleukin-B30 and related reagents
MXPA00000928A (en) Mammalian cytokine:interleukin-b30 and related reagents

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121108

MK4A Patent expired

Expiry date: 20180724